|
|
Informa Life Sciences
|
|
| 8th Annual Protein Kinases Congress 2009 |
|
|
|
|
|
|
| |
|
 |
|
|
|
|
| |
Tue 03 Mar 2009
- Wed 04 Mar 2009
Hotel Fira Palace, Barcelona, Spain
|
|
|
|
DRUG DISCOVERY TOOLS & TARGETS
1 Exhibition, 4 Conferences, 1 Location!
• GPCRs •
• Protein Kinases •
• Ion Channel Targets •
• High-Content Analysis •
Benefit from meeting delegates working on a range of different drug targets. Raise your corporate profile by sponsoring or exhibiting at this event. The 8th Annual Protein Kinases Congress brings together industry leaders from across the globe and is one of the most informative meetings in Europe.
This event caters for all groups working on protein kinases inhibitors. For those tackling cardiotoxicity, the Evening Seminar and Working Dinner provides a mechanistic insight into this critical field – can you overcome this major hurdle to the clinic?
With data-driven case-studies, enhanced networking opportunitites, new topics and an expanded clinical updates section, this is your best opportunity in 2009!
Join our online community now and network with other professionals in the field!
Click here
|
| |
|
Dont just take our word for it......
“An excellent overview of recent progress in protein kinase inhibitor development.”
Delegate 2008
|
|
| |
|
|
Don't Miss
Welcome back!
Informa Life Sciences is proud to announce the agenda for the 8th Annual Protein Kinases Congress
When?
Tuesday 3 - Wednesday 4 March 2009
Where?
Hotel Fira Palace, Barcelona, Spain
Moving from Berlin to the vibrant city of Barcelona, the congress will once again run alongside our annual meetings on GPCRs, Ion Channel Targets and High Content Analysis.
In 2008 the joint congress had around 350 attendees and 2009 looks set to be even bigger!
|
| |
|
|
“One of the best industry protein kinase meetings that I have ever attended.”
Delegate 2007
|
|
| |
|
Key Presentations
Brand new for 2009
- Understand the biomarker approaches approaches organisations are using in drug development and decide which is best for you
- Consider Schering Plough's novel cyclin dependent kinase inhibitor programmes for drug development
- Hear about effective marine toxins that target kinases for potential drug development
- Case study updates from the successful Gleevec and Aurora A inhibitors
- Discover the potential of non-ATP competitive kinase inhibitors
- Focus on kinase inhibitors for both oncology and inflammatory disorders
Speakers at the 2009 congress include:
- Doriano Fabbro, Head of Kinase Biology, Expertise Platform Kinases, Novartis Pharma AG, Switzerland
- Claude Cochet, Team Leader, INSERM, iRTSV, CEA, France
- Juergen Moll, Director Dep. Cell Biology, Nerviano Medical Sciences Srl., Italy
- Jaak Jarv, Institute of Cehmistry, University of Tartu, Estonia
- Steven Pelech, President and Chief Scientific Officer, Kinexus Bioinformatics Corporation, Professor, University of British Columbia, Canada
CLICK HERE TO DISCOVER THE FULL PANEL OF SPEAKERS
Plus don't miss:
Evening Seminar and Working Dinner | Tuesday 3 March 2009
Can we eliminate cardiotoxicity?
Led by
Miro Venturi, Head of Biomarker Development, Exploratory Development, Novartis Pharmaceuticals, Switzerland
Exhibit at the conference or become a sponsor!
The joint congress will be accompanied by a large exhibition hall. There are a wide range of sponsorship opportunities available. In 2008 speaking positions were quickly sold out and the exhibition space was fully booked. To make an early enquiry about sponsorship and exhibition at the meeting please contact Sukhvir Hayre at sukhvir.hayre@informa.com or visit www.informa-ls.com/targetsandtools for further information.
  
  
|
|
|
|
|
|
|
|
|